
A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patients
Keywords: فلوروکینولون; Cystic fibrosis; Antibiotics; Pseudomonas; Aerosol; Fluoroquinolone;